Hecq J-D
Université catholique de Louvain, cliniques universitaires UCL de Mont-Godinne, 1, avenue Therasse, 5530 Yvoir, Belgium.
Ann Pharm Fr. 2011 Jan;69(1):30-7. doi: 10.1016/j.pharma.2010.09.002. Epub 2010 Dec 30.
In hospitals, the major part of the drugs is administered by intravenous way and the majority of the reconstitution of injectable drugs are carried out right before the administration to the patient by the nursing staff. The risks and errors related to the preparation and the administration of the injectable drugs are numerous. The standardization then the centralization of the preparations and reconstitution by the hospital pharmacy make it possible to reduce these various risks and errors. In addition to the preparation of the mixtures of parenteral nutrition as well as doses of anticancer chemotherapy, many other treatments can be taken in charge, such as antibiotics, antiemetics and pain treatments. Consequent equipment is necessary but the realization of these treatments proves non-overdrawn insofar as a certain quantity of production is reached. The reconstitution of the intravenous treatments by a centralized intravenous admixture service guarantees the chemical stability and the microbiological quality of the ready-to-use injectable drugs and contributes to the quality and the total management of the care of the patient.
在医院里,大部分药物通过静脉途径给药,大多数注射用药物的复溶是由护理人员在即将给患者用药前进行的。与注射用药物的配制和给药相关的风险和差错众多。医院药房对制剂和复溶进行标准化进而集中化,能够降低这些各种风险和差错。除了配制肠外营养混合物以及抗癌化疗药物剂量外,还可以负责许多其他治疗,如抗生素、止吐药和疼痛治疗。相应的设备是必要的,但只要达到一定的产量,实施这些治疗就并非过度。由集中式静脉药物配置服务进行静脉治疗的复溶,可确保即用型注射用药物的化学稳定性和微生物质量,并有助于提高患者护理的质量和全面管理。